Human Genome picks up rights to cancer drug for $50 (Reuters)

[riky]

Human Genome picks up rights to cancer drug for $50
    (Reuters)

 


Reuters - Human Genome Sciences Inc said it will develop and commercialize a privately held biotech firm's drug for multiple cancers in the United States, Canada and European markets.


You are not allowed to view links. Register or Login/news.yahoo.com/s/nm/20110316/hl_nm/us_humangenome